New Delhi: HL July 14, 2026
Health authorities in Andhra Pradesh have intensified surveillance after two COVID-19-related deaths and eight positive cases were reported from Kadapa district. While the development has raised concerns, officials have stressed that the cases are isolated and do not indicate the beginning of a new COVID-19 outbreak.
The deaths are the first COVID-19-linked fatalities reported from Andhra Pradesh since 2022. According to the state health department, all identified cases are under close monitoring, and contact tracing has been initiated to prevent further transmission.
Two Fatal Cases Under Investigation
The first patient, a man in his early 60s, was initially admitted to a hospital in Tirupati before being referred to a tertiary care centre in Vellore, Tamil Nadu, for advanced treatment. He had multiple underlying health conditions, including diabetes and chronic kidney disease. After his death, an RT-PCR test confirmed COVID-19 infection.
The second fatality involved a 46-year-old man from Kadapa district who was admitted with severe breathlessness and persistent cough. Doctors reported extensive lung damage and pneumonia, and he died despite treatment. State health officials are reviewing his medical records to better understand the clinical course of the illness.
Eight Positive Cases Detected
Health officials said eight COVID-19 infections have been identified in Kadapa district. Five patients were initially diagnosed, while the remaining three were found during contact tracing. All infected individuals are being monitored, and surveillance activities have been strengthened in the district.
The Andhra Pradesh Health Department has clarified that the current cases are sporadic and there is no evidence of widespread community transmission.
Experts Urge Vigilance, Not Panic
Some clinicians have noted that a few patients developed respiratory complications quickly, prompting questions about whether a different Omicron subvariant could be involved. However, there is currently no scientific evidence confirming the circulation of a more aggressive strain.
Experts say genomic surveillance and laboratory investigations will provide a clearer picture if any significant variant emerges.
Tamil Nadu Rules Out Highly Virulent Variant
Amid public concern following the Andhra Pradesh cases, Tamil Nadu’s Directorate of Public Health has stated that there is no evidence of a highly virulent COVID-19 variant circulating in the state.
The department said COVID-19 activity remains lower than in previous years and that most infections continue to be mild. Whole Genome Sequencing conducted at the National Institute of Virology, Pune, has shown that the currently circulating variant is associated with mild illness and low community transmission.
Tamil Nadu also clarified details of patients treated in Vellore, noting that one patient had severe bacterial pneumonia along with COVID-19 and multiple pre-existing illnesses, while another cancer patient tested positive for COVID-19 incidentally during treatment. Officials said COVID-19 was not the sole cause of these complex medical cases.
Surveillance Continues
Tamil Nadu has continued routine COVID-19 surveillance through the Integrated Disease Surveillance Programme. Testing is being carried out for patients with severe respiratory illness, those not responding to treatment, and before major surgical procedures when required.
According to the Health Department, the state recorded 990 COVID-19 cases in 2024, 1,250 cases in 2025, and 335 cases so far in 2026, with most patients experiencing mild illness.
Public Health Advice
Health authorities in both Andhra Pradesh and Tamil Nadu have advised people not to panic but to remain cautious. Older adults, pregnant women, people with chronic illnesses, and those with weakened immunity are encouraged to maintain hand hygiene, practice cough etiquette, and seek medical attention if they develop persistent fever, cough, breathlessness, or other respiratory symptoms.
Officials have also urged the public to avoid misinformation and rely only on updates issued by government health departments and public health agencies.
